Nevirapine
- Generic Name
- Nevirapine
- Brand Names
- Viramune
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14N4O
- CAS Number
- 129618-40-2
- Unique Ingredient Identifier
- 99DK7FVK1H
Overview
A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
Background
A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
Indication
For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
Associated Conditions
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Clinical Trials
FDA Approved Products
Viramune
Manufacturer:Boehringer Ingelheim Pharmaceuticals Inc.
Route:ORAL
Strength:50 mg in 5 mL
Approved: 2022/06/17
NDC:0597-0047
Viramune
Manufacturer:Boehringer Ingelheim Pharmaceuticals Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2022/06/17
NDC:0597-0046
Nevirapine
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2022/08/03
NDC:31722-505
nevirapine
Manufacturer:Cipla Ltd.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2018/11/27
NDC:53104-0166
NEVIRAPINE
Manufacturer:Micro Labs Limited
Route:ORAL
Strength:200 mg in 1 1
Approved: 2022/07/15
NDC:42571-131
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath